Cleared Special

K132061 - RESTORELLE M, RESTORELLE XL (FDA 510(k) Clearance)

Aug 2013
Decision
30d
Days
Class 2
Risk

K132061 is an FDA 510(k) clearance for the RESTORELLE M, RESTORELLE XL. This device is classified as a Mesh, Surgical, Synthetic, Urogynecologic, For Apical Vaginal And Uterine Prolapse, Transabdominally Placed (Class II - Special Controls, product code OTO).

Submitted by Coloplast Corp. (Minneapolis, US). The FDA issued a Cleared decision on August 2, 2013, 30 days after receiving the submission on July 3, 2013.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 878.3300. Bridging Material To Attach The Vaginal Apex To The Anterior Longitudinal Ligament Of The Sacrum; Procedures Include Abdominal Sacrocolpopexy And Laparoscopic Sacrocolpopexy..

Submission Details

510(k) Number K132061 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2013
Decision Date August 02, 2013
Days to Decision 30 days
Submission Type Special
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code OTO — Mesh, Surgical, Synthetic, Urogynecologic, For Apical Vaginal And Uterine Prolapse, Transabdominally Placed
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3300
Definition Bridging Material To Attach The Vaginal Apex To The Anterior Longitudinal Ligament Of The Sacrum; Procedures Include Abdominal Sacrocolpopexy And Laparoscopic Sacrocolpopexy.